Here, we report the design of a nanoscale coordination polymer (NCP) encapsulating both GA and chemotherapeutic oxaliplatin (OX), OX/GA, to overcome the EPR limitation and markedly increase drug deposition in tumors through STING-mediated disruption of tumor vasculature. The gene discussed is STING1; the disease is neoplasm.